ADC Therapeutics (ADCT) Competitor Comparison
We are evaluating the key criteria listed to compare ADC Therapeutics (ADCT) against its competitors in the Biotechnology industry.
Market Capitalization
180 / 368Gross Profits
71 / 278Total Revenue
82 / 300EBITDA
241 / 337Free Cashflow
294 / 352Quick Ratio
206 / 357Earnings per Share
239 / 359Dividend yield
0 / 6Total Cash
110 / 358Performance 3 years
297 / 368Performance 5 years
284 / 368Performance 10 years
248 / 368Linearity 3 years
282 / 368Linearity 5 years
231 / 368Linearity 10 years
209 / 368Total Rank
7 / 368Dividend Rank
332 / 368Valuation Rank
86 / 368Piotroski Rank
56 / 368Muliplier Rank
57 / 368Dividend Rank - ADCT ranking 332 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.